A detailed history of Keystone Financial Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Keystone Financial Group holds 4,286 shares of LLY stock, worth $3.51 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
4,286
Previous 3,511 22.07%
Holding current value
$3.51 Million
Previous $2.73 Million 42.07%
% of portfolio
1.42%
Previous 0.4%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $561,774 - $704,506
775 Added 22.07%
4,286 $3.88 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $662,079 - $885,769
1,118 Added 46.72%
3,511 $2.73 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $70,375 - $82,963
-134 Reduced 5.3%
2,393 $1.39 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $290,379 - $400,332
668 Added 35.93%
2,527 $1.36 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $105,572 - $141,162
301 Added 19.32%
1,859 $871,000
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $51,448 - $59,947
160 Added 11.44%
1,558 $569,000
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $592 - $675
2 Added 0.14%
1,398 $452,000
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $4,180 - $4,909
-15 Reduced 1.06%
1,396 $453,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $3,755 - $4,666
16 Added 1.15%
1,411 $404,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $17,088 - $21,207
76 Added 5.76%
1,395 $385,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $180 - $233
1 Added 0.08%
1,319 $303,000
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $22,347 - $28,929
-136 Reduced 9.35%
1,318 $246,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $17,742 - $23,477
-136 Reduced 8.55%
1,454 $246,000
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $44,158 - $51,077
302 Added 23.45%
1,590 $235,000
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $175,708 - $211,463
1,288 New
1,288 $211,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Keystone Financial Group Portfolio

Follow Keystone Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.